Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10011658 Constructs targeting AFP peptide/MHC complexes and uses thereof

Patent 10011658 was granted and assigned to Eureka Therapeutics, Inc on July, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Eureka Therapeutics, Inc

Current Assignee

Eureka Therapeutics, Inc

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

July 3, 2018

Patent Application Number

15829783

Date Filed

December 1, 2017

Patent Citations Received

US Patent 11421013 Antibody/T-cell receptor chimeric constructs and uses thereof

US Patent 11344578 Immune cells expressing engineered antigen receptors

US Patent 11976105 Antibody/T-cell receptor chimeric constructs and uses thereof

0

US Patent 11965021 Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof

0

US Patent 10098951 Antibody/T-cell receptor chimeric constructs and uses thereof

US Patent 10464988 Antibody/T-cell receptor chimeric constructs and uses thereof

US Patent 10822389 Antibody/T-cell receptor chimeric constructs and uses thereof

Patent Primary Examiner

Anne Marie S. Wehbe′

Patent abstract

The present application provides constructs comprising an antibody moiety that specifically binds to a complex comprising an AFP peptide and an MHC class I protein. Also provided are methods of making and using these constructs.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10011658 Constructs targeting AFP peptide/MHC complexes and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool